Shuya Zhang1,2, Huan Liu1,2, Meimei Yin1, Xiuying Pei2, Angelika Hausser3, Eri Ishikawa4,5, Sho Yamasaki4,5, Zheng Gen Jin1. 1. Department of Medicine, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY. 2. Key Laboratory of Fertility Preservation and Maintenance of Ministry of Education, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China. 3. Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany. 4. Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan. 5. Molecular Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
Abstract
BACKGROUND AND AIMS: Liver fibrosis (LF) is a central pathological process that occurs in most types of chronic liver diseases. Advanced LF causes cirrhosis, hepatocellular carcinoma, and liver failure. However, the exact molecular mechanisms underlying the initiation and progression of LF remain largely unknown. APPROACH AND RESULTS: This study was designed to investigate the role of protein kinase D3 (PKD3; gene name Prkd3) in the regulation of liver homeostasis. We generated global Prkd3 knockout (Prkd3-/- ) mice and myeloid-cell-specific Prkd3 knockout (Prkd3∆LysM ) mice, and we found that both Prkd3-/- mice and Prkd3∆LysM mice displayed spontaneous LF. PKD3 deficiency also aggravated CCl4 -induced LF. PKD3 is highly expressed in hepatic macrophages (HMs), and PKD3 deficiency skewed macrophage polarization toward a profibrotic phenotype. Activated profibrotic macrophages produced transforming growth factor beta that, in turn, activates hepatic stellate cells to become matrix-producing myofibroblasts. Moreover, PKD3 deficiency decreased the phosphatase activity of SH2-containing protein tyrosine phosphatase-1 (a bona-fide PKD3 substrate), resulting in sustained signal transducer and activator of transcription 6 activation in macrophages. In addition, we observed that PKD3 expression in HMs was down-regulated in cirrhotic human liver tissues. CONCLUSIONS: PKD3 deletion in mice drives LF through the profibrotic macrophage activation.
BACKGROUND AND AIMS: Liver fibrosis (LF) is a central pathological process that occurs in most types of chronic liver diseases. Advanced LF causes cirrhosis, hepatocellular carcinoma, and liver failure. However, the exact molecular mechanisms underlying the initiation and progression of LF remain largely unknown. APPROACH AND RESULTS: This study was designed to investigate the role of protein kinase D3 (PKD3; gene name Prkd3) in the regulation of liver homeostasis. We generated global Prkd3 knockout (Prkd3-/- ) mice and myeloid-cell-specific Prkd3 knockout (Prkd3∆LysM ) mice, and we found that both Prkd3-/- mice and Prkd3∆LysM mice displayed spontaneous LF. PKD3 deficiency also aggravated CCl4 -induced LF. PKD3 is highly expressed in hepatic macrophages (HMs), and PKD3 deficiency skewed macrophage polarization toward a profibrotic phenotype. Activated profibrotic macrophages produced transforming growth factor beta that, in turn, activates hepatic stellate cells to become matrix-producing myofibroblasts. Moreover, PKD3 deficiency decreased the phosphatase activity of SH2-containing protein tyrosine phosphatase-1 (a bona-fide PKD3 substrate), resulting in sustained signal transducer and activator of transcription 6 activation in macrophages. In addition, we observed that PKD3 expression in HMs was down-regulated in cirrhotic human liver tissues. CONCLUSIONS: PKD3 deletion in mice drives LF through the profibrotic macrophage activation.
Authors: Johanna Vollmar; Yong Ook Kim; Jens U Marquardt; Diana Becker; Peter R Galle; Detlef Schuppan; Tim Zimmermann Journal: Am J Physiol Gastrointest Liver Physiol Date: 2019-06-26 Impact factor: 4.052
Authors: Huan Liu; Shuya Zhang; Suowen Xu; Marina Koroleva; Eric M Small; Zheng Gen Jin Journal: Biochem Biophys Res Commun Date: 2019-05-10 Impact factor: 3.575
Authors: Ling Lu; Shi Yue; Longfeng Jiang; Changyong Li; Qiang Zhu; Michael Ke; Hao Lu; Xuehao Wang; Ronald W Busuttil; Qi-Long Ying; Jerzy W Kupiec-Weglinski; Bibo Ke Journal: Hepatology Date: 2018-01-24 Impact factor: 17.298
Authors: Kevin M Vannella; Luke Barron; Lee A Borthwick; Kristen N Kindrachuk; Prakash Babu Narasimhan; Kevin M Hart; Robert W Thompson; Sandra White; Allen W Cheever; Thirumalai R Ramalingam; Thomas A Wynn Journal: PLoS Pathog Date: 2014-09-11 Impact factor: 6.823
Authors: Jonathan Trujillo-Viera; Rabih El-Merahbi; Vanessa Schmidt; Till Karwen; Angel Loza-Valdes; Akim Strohmeyer; Saskia Reuter; Minhee Noh; Magdalena Wit; Izabela Hawro; Sabine Mocek; Christina Fey; Alexander E Mayer; Mona C Löffler; Ilka Wilhelmi; Marco Metzger; Eri Ishikawa; Sho Yamasaki; Monika Rau; Andreas Geier; Mohammed Hankir; Florian Seyfried; Martin Klingenspor; Grzegorz Sumara Journal: EMBO Mol Med Date: 2021-05-05 Impact factor: 12.137
Authors: Jiří Koutník; Verena Neururer; Thomas Gruber; Sebastian Peer; Natascha Hermann-Kleiter; William J Olson; Verena Labi; Michael Leitges; Gottfried Baier; Kerstin Siegmund Journal: Cell Commun Signal Date: 2022-04-19 Impact factor: 7.525
Authors: Angel Loza-Valdes; Alexander E Mayer; Toufic Kassouf; Jonathan Trujillo-Viera; Werner Schmitz; Filip Dziaczkowski; Michael Leitges; Andreas Schlosser; Grzegorz Sumara Journal: Life Sci Alliance Date: 2021-06-18